Loading stock data…
Solesence, Inc. (SLSN)
$0.87+0.02 (+2.30%)
Market ClosedLast close Sep 8
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Solesence, Inc. in the Consumer Defensive sector is trading at $0.87 with a market capitalization of $61M. The stock is currently near its 52-week low of $0.61, remaining 31.6% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $12.96M↑ | $12.48M↓ | $14.60M↓ | $20.36M↑ | $14.63M |
| Gross Profit | $3.34M↓ | $3.43M↑ | $3.37M↓ | $5.88M↑ | $3.38M |
| Operating Income | -$504,000↓ | $186,000↑ | -$781,000↓ | $1.91M↑ | $256,000 |
| Net Income | -$766,000↓ | $163,000↑ | -$1.12M↓ | $2.67M↑ | $80,000 |
Peer Comparison
Fundamentals
Solesence, Inc., a science-driven company, provides engineered materials, formulation development, and commercial manufacturing services in the United States. The company engages in the manufacture and supply of surface engineered zinc oxide and tita...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$61.36M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.27
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-14.30%
Volume
Today's trading volume
11,996
Recent News
SLSN's Earnings Break-Even in Q2, High Operating Costs Hurt
Solesence's Q2 results are pressured by higher operating expenses, but improving production efficiency and expectations for a stronger second half provide reasons for optimism.
Solesence, Inc. Common Stock Q2 2026 Earnings Call Summary
Moby summary of Solesence, Inc. Common Stock's Q2 2026 earnings call
Solesence Inc (SLSN) (Q2 2026) Earnings Call Highlights: Strong Order Book Signals Record ...
Company projects $35 million in second-half revenue and expands into scalp care while navigating inventory costing issues.
SLSN Unveils Two Scalp Care Products Using Patented Technology
Solesence expands its scalp care portfolio with a barrier-repair serum and SPF 45+ dry shampoo powered by patented technologies for hydration, oil control and UV protection.
Solesence (SLSN) Q4 2025 Earnings Transcript
Kevin Cureton: Thank you, operator, and thank you to our investors, brand partners and teammates who are joining us today. To walk you through how we wrapped up 2025, I'll turn the call over to our CFO, Laura Riffner. Laura Riffner: Thank you, Kevin.